This guidance provides recommendations for increasing enrollment of females in clinical trials, analyzing and interpreting sex-specific data, and including sex-specific information in regulatory submissions of medical products
Similar Posts
Kuka Flex Forte contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Kuka Flex Forte, a product promoted and sold for joint pain and arthritis on various websites, including https://botanical-be.com, and possibly in some retail stores.Aquastar (USA) Corp Recalls Cocktail Shrimp 6oz Because of Possible Health Risk
August 28, 2025, AquaStar (USA) Corp of Seattle, WA is recalling approximately 26,460 packages of Cocktail Shrimp 6oz (see photo), imported from Indonesia, because they may have been prepared, packed, or held under insanitary conditions whereby they may have become contaminated with cesium-137 (Cs-1Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studieswww.d-pharmacy.com – 711075 – 07/16/2025
Unapproved New Drugs/MisbrandedMobile Lift Component Recall: Baxter Healthcare Corporation Removes Mobile Lift Component due to Risk of Improper Attachment
Baxter is removing mobile lift components due to risk of false attachment, which may result in patient injury due to falls.Boothwyn Pharmacy LLC. Kennett Square, PA. 483 issued 06/09/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/09/2025
Short Title (70 char) Boothwyn Pharmacy LLC. Kennett Square, PA. 483 issued 06/09/2025
FEI Number 1000076625
Firm Name Boothwyn Pharmacy LLC
Record Type 483
State PA
Establishment Type Producer of Ste